Clinical Efficacy of Intense Pulsed Light Therapy in Treating Meibomian Gland Dysfunction among Glaucoma Patients
10.3341/jkos.2025.66.5.215
- Author:
Kwang Eon HAN
1
;
Sang Woo MOON
;
Su Jin KIM
;
Ji Eun LEE
Author Information
1. Department of Ophthalmology, Pusan National University Yangsan Hospital, Pusan National University College of Medicine, Yangsan, Korea
- Publication Type:Original Article
- From:Journal of the Korean Ophthalmological Society
2025;66(5):215-223
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose:To evaluate the clinical efficacy of intense pulsed light (IPL) therapy combined with meibomian gland expression (MGX) in treating meibomian gland dysfunction (MGD) caused by glaucoma eye drops.
Methods:This study included 20 patients (aged 18-85 years) who were using glaucoma eye drops and exhibited signs of MGD. Participants underwent four sessions of IPL therapy at 3-week intervals, each followed by MGX. Evaluative measures included the Ocular Surface Disease Index (OSDI), best-corrected visual acuity, Schirmer's test, tear break-up time (TBUT), corneal fluorescein staining score (CFS), lid margin abnormalities, meibomian gland expressibility (MGE), meibum quality, lipid layer thickness (LLT), and meiboscore. These assessments were conducted before and after each treatment.
Results:After treatment, significant improvements were observed across all measured parameters, including OSDI, Schirmer's test, TBUT, CFS, lid margin abnormalities, MGE, meibum quality, LLT, and meiboscore.
Conclusions:IPL therapy combined with MGX was effective in improving ocular surface and eyelid abnormalities among patients with MGD induced by glaucoma eye drops. Our findings support the use of IPL and MGX as safe and effective adjunct therapies for these patients.
